The investigators noted that the HYPERION trial had lost clinical equipoise based on robust evidence of clinical benefit from other trials. A phase 3 trial evaluating sotatercept-csrk (Winrevair ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback